U.S. Construction Stock News

Why these corporate moves matter for Dime Community Bancshares (DCOM) shareholders Dime Community Bancshares (DCOM) has rolled out a cluster of corporate changes, including leadership appointments in key lending units, a planned rebrand to Dime Commercial Bank, an exchange transfer, debt redemption, and a refreshed buyback authorization. Together, these steps provide a clearer view of how management is positioning the bank around commercial lending, while also adjusting its capital structure...

QUALCOMM (QCOM) has been in focus after launching its Dragonwing robotics processor, joining a new AI native 6G coalition, and securing fresh AI and data center attention from partners and analysts. See our latest analysis for QUALCOMM. Despite the recent AI, 6G and robotics headlines, Qualcomm’s 2026 share price performance has been weak, with a year to date share price return of 19.35% and a 1 year total shareholder return of 9.43%. However, the 3 year and 5 year total shareholder returns...

If you are wondering whether Equitable Holdings is attractively priced right now or if the market already reflects its potential, this article is designed to help you assess that question with a clear focus on value. The stock last closed at US$39.78, with returns of 49.9% over 3 years and 41.7% over 5 years. More recently, the share price has moved lower, with a 5.1% decline over 7 days, an 11.0% decline over 30 days, a 17.1% decline year to date, and an 18.3% decline over 1 year. Recent...

If you are wondering whether Mondelez International is offering fair value right now, it helps to look past the headline price and focus on what different valuation methods are actually saying. The stock last closed at US$58.19, with a 7 day return of a 2.9% decline and a 30 day return of a 2.2% decline, while the year to date return stands at 8.5% and the 1 year return at a 10.1% decline. Recent news around Mondelez International has focused on its role as a large branded snacks and...

Why SLB Is Back in Focus After New Oman Contracts and Q4 Beat SLB (SLB) is back on many watchlists after announcing two five year contracts with Petroleum Development Oman, along with recent stock outperformance and better than expected Q4 2025 earnings. The Oman deals cover wellheads and artificial lift technologies for Block 6, the country’s largest oil and gas concession, and include plans to expand in country manufacturing and launch made in Oman gate valve production. See our latest...

Power Solutions International (PSIX) has come under the spotlight after its fourth quarter and full year 2025 earnings showed strong sales, softer quarterly profitability, and an acquisition aimed at tightening its data center supply chain. See our latest analysis for Power Solutions International. The market reaction has been sharp, with a 1 week share price return of 37.18% decline and a 1 month share price return of 16.72% decline following the earnings release and MTL acquisition news...

Exxon Mobil (NYSE:XOM) is rerouting fuel shipments after conflict in the Middle East disrupts oil flows through the Strait of Hormuz. Recent US and Israeli strikes on Iran have effectively closed this key shipping route, prompting Exxon Mobil to adjust export paths. The company is set to ship 600,000 barrels of fuel from the US Gulf Coast to Australia as part of its response to the disruption. For you as an investor, this matters because Exxon Mobil is a large, integrated energy company...

Why Amprius Technologies Stock Is Getting Attention Amprius Technologies (AMPX) has been drawing fresh interest after a stretch of strong multi period returns and rapid reported growth in both revenue and net income, prompting investors to reassess expectations around this battery maker. See our latest analysis for Amprius Technologies. The current share price of US$14.89 comes after a sharp 18.65% 1 day share price return and a 29.25% 7 day share price return, adding to a strong year to date...

Why UroGen Pharma (URGN) is on investors’ radar today UroGen Pharma (URGN) has drawn fresh attention after recent trading saw the stock close at $20.16, with a 7.1% move over the past day and mixed returns over the past year. See our latest analysis for UroGen Pharma. The latest 1 day share price return of 7.1% at $20.16 comes after mixed short term moves, including a 30 day share price return of 2.3% and a 90 day share price decline of 17.0%. Meanwhile, the 1 year total shareholder return of...

In late February and early March 2026, SiTime participated in high-profile investor conferences hosted by Raymond James in Orlando and Morgan Stanley in San Francisco, where CEO Rajesh Vashist and CFO Elizabeth Howe addressed institutional investors. These appearances came shortly after heightened AI-focused sector commentary and SiTime’s acquisition of Renesas’ timing business, drawing extra attention to its exposure to AI data center infrastructure. Now we’ll examine how this increased...

If you are looking at First American Financial and wondering whether the current share price lines up with the underlying value, you are not alone. The stock last closed at US$69.03, with returns of 1.1% over 7 days, 6.7% over 30 days, 13.0% year to date, 11.7% over 1 year, 41.4% over 3 years and 40.3% over 5 years, which gives plenty of context for a closer look at pricing. Recent news around First American Financial has focused on ongoing interest in title insurance and related financial...

Stock performance snapshot and recent returns Lionsgate Studios (LION) has caught investors' attention after a recent move in its share price. The stock closed at $9.43, with a 3.85% gain over the past day and 14.44% over the past week. Looking at slightly longer periods, the shares show a 2.17% return over the past month and 32.82% over the past 3 months. The 1 year total return stands at 18.31%, and the 3 year total return at 11.86%. See our latest analysis for Lionsgate Studios. The recent...

Verizon Communications (NYSE:VZ), Aptiv and Wind River have introduced a proof-of-concept connected-driving V2X platform. The solution uses Verizon's 5G network and edge compute capabilities to let vehicles share real-time sensor data. The platform is designed to support safety-related and cooperative driving features without requiring specialized in-vehicle hardware. For Verizon, this project sits at the intersection of its core 5G connectivity business and the broader push toward...

Conference appearance puts Doximity (DOCS) in focus for telehealth investors Doximity (DOCS) heads into its ViVE 2026 conference appearance in Los Angeles, with CEO Jeffrey Tangney presenting, keeping attention on how its digital tools and telemedicine platform might support the business. See our latest analysis for Doximity. Despite the upcoming ViVE appearance and interest in its telehealth tools, Doximity’s share price return has been weak over longer periods. It has a 30 day share price...

NVIDIA (NasdaqGS:NVDA) is committing a total of $4b to advanced optics technology through multiyear partnerships with Coherent and Lumentum. The company plans to allocate roughly $2b to each partner to support next generation AI infrastructure and silicon photonics. These agreements aim to secure long term access to critical components for high bandwidth, energy efficient AI data center networks. NVIDIA is best known for its GPUs that power AI training and inference in large scale data...

Why 3M (MMM) is back in focus after Q4 2025 3M (MMM) is drawing fresh attention after its Q4 2025 earnings showed a 20% year over year EPS drop tied to special items, including litigation and PFAS related charges. For investors, that combination of pressured earnings, underperformance versus the S&P 500, and continued Wall Street coverage raises practical questions about how to evaluate the stock today. See our latest analysis for 3M. At a latest share price of US$160.89, 3M’s 1 month share...

Yelp (YELP) put its product roadmap in the spotlight at the Morgan Stanley Technology, Media & Telecom Conference, outlining how AI, new partnerships and an acquisition could reshape its platform and advertising economics. See our latest analysis for Yelp. Yelp's recent focus on AI partnerships and the Hatch acquisition comes as the share price has seen short term momentum, with a 1 day share price return of 2.42% and 7 day return of 11.77%, compared with a 1 year total shareholder return...

POET Technologies previously entered securities purchase agreements with institutional investors for a registered direct offering of about US$150 million to fund corporate development, targeted acquisitions and expansion of its high-speed optical module and light-source initiatives, alongside rising short interest and increased institutional ownership. At the same time, unusually heavy call option activity and higher implied volatility highlighted how traders are positioning around the...

USA Rare Earth, ticker NasdaqGM:USAR, has signed a definitive agreement to acquire all outstanding shares of Texas Mineral Resources Corp. The transaction will give USA Rare Earth 100% ownership and operational control of the Round Top rare earth project in Texas. The company positions this deal as a step toward building a vertically integrated U.S. supply source for critical minerals used in defense and manufacturing. USA Rare Earth shares last closed at $18.91, with the stock up 33.6%...

Why Garmin Stock Is Back on Investors’ Radar Garmin (GRMN) has drawn fresh attention after a month in which the stock returned about 21%, extending a gain of roughly 24% over the past 3 months and modestly outpacing its 1 year total return. With the shares last closing at US$251.18 and year to date performance of about 24%, some investors are rechecking how this price lines up against Garmin’s recent financial profile, including revenue of US$7,245.519m and net income of US$1,663.887m. See...

Stock performance snapshot and recent moves Pulse Biosciences (PLSE) has recently drawn investor attention after a month return of 32% and a past 3 months return of 36.4%, with the shares last closing at US$18.10. Over a longer horizon, the stock shows a year to date return of 35.2% and a 1 year total return of 2.5%. The 3 year total return figure is very large at about 7x. At the same time, the 5 year total return sits at a 37.2% decline, giving investors a mixed performance picture that may...

Aardvark Therapeutics (AARD) has put its Phase 3 HERO trial for ARD-101 in Prader-Willi Syndrome on hold after reversible cardiac issues at higher doses, triggering delays, legal scrutiny, and sharp share price swings. See our latest analysis for Aardvark Therapeutics. The HERO trial pause has been the clear driver of volatility, with Aardvark Therapeutics’ 1-day share price return of 15.1% coming after sharp declines, including a 57.6% 30-day share price loss and a 50.4% 1-year total...

This article is intended to help you assess whether Hims & Hers Health at around US$16.45 still offers value or whether most of the opportunity is already reflected in the share price. The stock has returned 4.0% over the last 7 days, compared with a 30 day return of a 37.8% decline, a year to date return of a 50.8% decline and a 1 year return of a 59.8% decline, while the 3 year and 5 year returns stand at 66.5% and 24.4% respectively. These mixed returns have kept Hims & Hers Health on the...

Recent performance snapshot Thermo Fisher Scientific (TMO) has been on many investors’ radar after a period of weaker share performance, with the stock showing negative returns over the past month, past 3 months and year to date. At a last close of $512.69, the company shows a 1 day return of 0.9% and a 7 day return that is close to flat. Over the past month and past 3 months, returns are each in the low double digit decline range. Over a 1 year period, the total return sits in the low single...